Paxman Past Earnings Performance

Past criteria checks 3/6

Paxman has been growing earnings at an average annual rate of 1.4%, while the Medical Equipment industry saw earnings growing at 5.8% annually. Revenues have been growing at an average rate of 21.8% per year. Paxman's return on equity is 6.7%, and it has net margins of 3.7%.

Key information

1.4%

Earnings growth rate

2.8%

EPS growth rate

Medical Equipment Industry Growth6.2%
Revenue growth rate21.8%
Return on equity6.7%
Net Margin3.7%
Next Earnings Update23 May 2024

Recent past performance updates

Recent updates

Does Paxman (STO:PAX) Have A Healthy Balance Sheet?

Dec 23
Does Paxman (STO:PAX) Have A Healthy Balance Sheet?

Paxman (STO:PAX) Shareholders Will Want The ROCE Trajectory To Continue

Aug 25
Paxman (STO:PAX) Shareholders Will Want The ROCE Trajectory To Continue

Paxman AB (publ) (STO:PAX) Could Be Riskier Than It Looks

Jun 01
Paxman AB (publ) (STO:PAX) Could Be Riskier Than It Looks

Does Paxman (STO:PAX) Have A Healthy Balance Sheet?

Nov 20
Does Paxman (STO:PAX) Have A Healthy Balance Sheet?

Is Paxman (STO:PAX) A Risky Investment?

Mar 07
Is Paxman (STO:PAX) A Risky Investment?

Paxman (STO:PAX) Is Making Moderate Use Of Debt

Mar 15
Paxman (STO:PAX) Is Making Moderate Use Of Debt

Are Insiders Buying Paxman AB (publ) (STO:PAX) Stock?

Jan 22
Are Insiders Buying Paxman AB (publ) (STO:PAX) Stock?

Reflecting on Paxman's (STO:PAX) Share Price Returns Over The Last Year

Dec 18
Reflecting on Paxman's (STO:PAX) Share Price Returns Over The Last Year

Revenue & Expenses Breakdown
Beta

How Paxman makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

OM:PAX Revenue, expenses and earnings (SEK Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Dec 232218590
30 Sep 232081940
30 Jun 23188-2900
31 Mar 23173-7880
31 Dec 22157-10850
30 Sep 22143-2730
30 Jun 22125-12700
31 Mar 22111-18650
31 Dec 21105-13620
30 Sep 2193-23610
30 Jun 2187-21570
31 Mar 2180-22540
31 Dec 2083-19540
30 Sep 2090-6560
30 Jun 2096-1560
31 Mar 201026580
31 Dec 19963570
30 Sep 1990-4500
30 Jun 1983-5490
31 Mar 1975-6470
31 Dec 1869-7460
30 Sep 1858-9370
30 Jun 1850-10350
31 Mar 1843-9330
31 Dec 1736-7310

Quality Earnings: PAX has high quality earnings.

Growing Profit Margin: PAX became profitable in the past.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: PAX has become profitable over the past 5 years, growing earnings by 1.4% per year.

Accelerating Growth: PAX has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.

Earnings vs Industry: PAX has become profitable in the last year, making it difficult to compare its past year earnings growth to the Medical Equipment industry (30.1%).


Return on Equity

High ROE: PAX's Return on Equity (6.7%) is considered low.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.